Biomedcl Res Fdn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOMEDCL RES FDN, and what generic and branded alternatives to BIOMEDCL RES FDN drugs are available?
BIOMEDCL RES FDN has four approved drugs.
Summary for Biomedcl Res Fdn
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Biomedcl Res Fdn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomedcl Res Fdn | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203710-001 | May 1, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biomedcl Res Fdn | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203837-001 | May 1, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biomedcl Res Fdn | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204352-001 | May 1, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biomedcl Res Fdn | SODIUM FLUORIDE F-18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 204351-001 | Jan 9, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
